Antiparasitic properties of homoallylamines and related compounds

Acta Parasitologica

Volumn 51, Issue 1, 2006, Pages 73-78

  Gómez Barrio, Alicia ^a   Montero Pereira, David ^a   Nogal Ruiz, Juan J ^a   Escario, José A ^a   Muelas Serrano, Susana ^a   Kouznetsov, Vladimir V ^b   Vargas Méndez, Leonor Y ^b   Urbina Gonzáles, Juan M ^b   Ochoa, Carmen ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^c INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

Antichagasic; Homoallylamines; Quinolines; Tetrahydroquinolines; Trichomonacidal; Unspecific cytotoxicity

Indexed keywords

MURINAE; TRICHOMONAS VAGINALIS; TRYPANOSOMA CRUZI;

EID: 33646009672     PISSN: 12302821     EISSN: None     Source Type: Journal    
DOI: 10.2478/s11686-006-0010-z     Document Type: Article

References (24)

1. Andrade S.G., Magalhaes J.B., Pontes A.L. 1985. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization, 63, 721-726.
2. Bowden F.J., Garnett G.P. 1999. Why is Trichomonas vaginalis ignored? Sexually Transmitted Infections, 75, 372-374.
3. Cancado J.R. 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Revista do Instituto de Medicina Tropical de São Paulo, 44, 29-37.
4. Cedillo-Rivera R., Ramirez A., Muñoz O. 1992. A rapid colorimetric assay with the tetrazolium salt MTT and phenazine methosulfate (PMS) for viability of Entamoeba histolytica. Archives of Medical Research, 23, 59-61.
5. Coura J.R., Castro S.L. de 2002. A critical review on Chagas disease chemotherapy. Memorias do Instituto Oswaldo Cruz, 97, 3-24.
6. Crowell A.L., Sanders-Lewis K.A., Secor E. 2003. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy, 47, 1407-1409.
7. Dunne R.L., Dunn L.A., Upcroft P., O'Donoghue P.J., Upcroft J.A. 2003. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Research, 13, 239-249.
8. Filardi L.S., Brener Z. 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 755-759.
9. Fournet A., Barrios A.A., Munoz V., Hocquemiller R., Cave A., Bruneton J. 1993. 2-substituted quinoline alkaloids as potential antileishmanial drugs. Antimicrobial Agents and Chemotherapy, 37, 859-863.
10. Hattori Y., Nakanishi N. 1995. Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cellular Immunology, 165, 7-11.
11. Jonckers T.H., Miert S. van, Cimanga K., Bailly C., Colson P., De Pauw-Gillet M.C., Heuvel H. van den, Claeys M., Lemiere F., Esmans E.L., Rozenski J., Quirijnen L., Maes L., Dommisse R., Lemiere G.L., Vlietinck A., Pieters L. 2002. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. Journal of Medicinal Chemistry, 45, 3497-3508.
12. Kouznetsov V.V., Palma A.R., Aliev A.E. 1998a. Chemistry of the functionalized benzazepines. 4[1]. Synthesis and stereo-chemistry of the 3,5-di- and 1,3,5-trisubstituted tetrahydrobenz-2-azepines. Anales de Química. Internacional Edition, 94, 132-135.
13. Kouznetsov V.V., Ocal N., Turgut Zh., Zubkov F., Kaban S., Varlamov A. 1998b. Allylation and heteroaddition reactions of aldimines: furan- and quinolinecarboxaldehydes. Monatshefte für Chemie, 29, 671-677.
14. Kouznetsov V.V., Vargas L.Y., Tibaduiza B., Ochoa C., Montero D., Nogal J.J., Fernández C., Muelas S., Gómez-Barrio A., Bahsas A., Amaro-Luis J. 2004. 4-Aryl(benzyl)amino-4-heteroarylbut-1-enes as building blocks in heterocyclic synthesis. 4[1]. Synthesis of 4,6-dimethyl-5-nitro(amino)-2-pyridylquinolines and their antiparasitic activities. Archiv der Pharmazie, 337, 127-132.
15. Lo M., Reid M., Brokenshire M. 2002. Resistance of Trichomonas vaginalis infections to metronidazole in Auckland sexual health clinics: report of two cases. New Zealand Medical Journal, 115, No. 1160.
16. Muelas-Serrano S., Nogal-Ruiz J.J., Gómez-Barrio A. 2000. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes. Parasitology Research, 86, 999-1002.
17. Organización Panamericana de la Salud. 1994. Las condiciones de salud en las Américas. Organización Panamerica de la Salud. Publicación Científica (1) 549. Washington, D.C.
18. Sorvillo F., Kerndt P. 1998. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet, 351, 213-214.
19. Sorvillo F., Smith L., Kerndt P., Ash L. 2001. Trichomonas vaginalis, HIV, and African-Americans. Emerging Infectious Diseases, 7, 927-932.
20. Toledo M.J.O., Guilherme A.L.F., Silva J.C., Gasped M.V., Mendes A.P., Gomes M.L., Marqués de Araujo S. 1997. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Parana state and from different endemic areas of Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 39, 283-290.
21. Tracy J. W., Wester T. 2001. The pharmaceutical basis of therapeutics. McGraw-Hill, New York.
22. Urbina G.J.M., Cortés J.C., Palma A., López S.N., Zacchino S.A., Enriz R.D., Ribas J.C., Kouznetsov V.V. 2000. Inhibitors of the fungal cell wall. Synthesis of 4-aryl-4-N-arylamine-1-butenes and related compounds with inhibitory activities on β(1-3) glucan and chitin syntheses. Bioorganic and Medicinal Chemistry, 8, 691-698.
23. Vargas M.L.Y., Castelli M.V., Kouznetsov V.V., Urbina G.J.M., López S.N., Sortino M., Enriz R.D., Ribas J.C., Zacchino S.A. 2003. In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers. Bioorganic and Medicinal Chemistry, 11, 1531-1550.
24. World Health Organization 1995. An overview of selected curable sexually transmitted diseases. In global program on AIDS. World Health Organization, Geneva.